This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08227/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08227/identifier/pdb/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08227/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08227/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08227/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08227
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08227 n10:DB08227
dcterms:title
1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE
adms:identifier
n8:19989057 n9:99444698 n12:DB08227 n13:MXT n14:14512737
n3:IUPAC-Name
n4:271B43A3-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B43A9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B43A8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B43A5-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B43A6-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B43A7-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B43A1-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B43A2-363D-11E5-9242-09173F13E4C5 n4:271B439F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B43A0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B43AF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B43B0-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B43AA-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B43AB-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B43AD-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B43AC-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B43AE-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B43B5-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B43B7-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B43B8-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B43B4-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B43B3-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B43B6-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B43A4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B43B1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B43B2-363D-11E5-9242-09173F13E4C5